Equities

Johnson Health Tech Co Ltd

1736:TAI

Johnson Health Tech Co Ltd

Actions
Consumer DiscretionaryLeisure Goods
  • Price (TWD)146.00
  • Today's Change6.00 / 4.29%
  • Shares traded934.55k
  • 1 Year change+106.51%
  • Beta--
Data delayed at least 20 minutes, as of Nov 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Nov-23
  • 15-Aug-24
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy2
Outperform0
Hold1
Sell0
Strong Sell0

Share price forecast in TWD

The 2 analysts offering 12 month price targets for Johnson Health Tech. Co., Ltd. have a median target of 181.50, with a high estimate of 185.00 and a low estimate of 178.00. The median estimate represents a 24.32% increase from the last price of 146.00.
High26.7%185.00
Med24.3%181.50
Low21.9%178.00

Dividends

In 2023, Johnson Health Tech Co Ltd reported a dividend of 1.00 TWD, which represents a 66.46% increase over last year. The 2 analysts covering the company expect dividends of 2.45 TWD for the upcoming fiscal year, an increase of 145.31%.
Div growth (TTM)66.46%
More ▼

Earnings history & estimates in TWD

On Nov 08, 2024, Johnson Health Tech. Co., Ltd. reported 3rd quarter 2024 earnings of 1.57 per share.
The next earnings announcement is expected on Mar 12, 2025.
Average growth rate+69.89%
Johnson Health Tech. Co., Ltd. reported annual 2023 earnings of 2.34 per share on Mar 14, 2024.
Average growth rate+228.87%
More ▼

Revenue history & estimates in TWD

Johnson Health Tech. Co., Ltd. had 3rd quarter 2024 revenues of 12.08bn. This bettered the 11.94bn consensus of the 2 analysts covering the company. This was 71.63% above the prior year's 3rd quarter results.
Average growth rate+10.04%
Johnson Health Tech. Co., Ltd. had revenues for the full year 2023 of 38.07bn. This was 13.26% above the prior year's results.
Average growth rate+10.69%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.